Success of experimental Alzheimer’s drug hailed as ‘historic moment’
An experimental drug has slowed the rate of memory and thinking decline in people with early-stage Alzheimer’s disease in what is being described as a ‘historic moment’ for dementia treatment. The cognition of Alzheimer’s patients receiving the drug, developed by Eisai and Biogen, declined 27% less than those on placebo treatment after 18 months. This …
Success of experimental Alzheimer’s drug hailed as ‘historic moment’ Read More »